Literature DB >> 6027078

Abnormalities of high density lipoproteins in abetalipoproteinemia.

J W Jones, P Ways.   

Abstract

DETAILED STUDIES OF THE HIGH DENSITY LIPOPROTEINS FROM THREE PATIENTS WITH ABETALIPOPROTEINEMIA HAVE REVEALED THE FOLLOWING PRINCIPAL ABNORMALITIES: 1) High density lipoprotein 3 (HDL3) is reduced in both absolute and relative concentration, although HDL2 is present in normal amounts. 2) The phospholipid distribution of both HDL fractions is abnormal, with low concentrations of lecithin and an increased percentage (though normal absolute quantity) of sphingomyelin. 3) In both HDL fractions, lecithin contains less linoleate and more oleate than normal. The cholesteryl esters are also low in linoleic acid, and the sphingomyelin is high in nervonic acid. Dietary intake influences the linoleic acid concentration within 2 weeks, and perhaps sooner, but the elevated sphingomyelin nervonic acid is little affected by up to 6 months of corn oil supplementation. Qualitatively similar changes in fatty acid composition, but not phospholipid distribution, are also found in other malabsorption states. The available evidence suggests that the abnormally low levels of HDL3 and the deranged phospholipid distribution are more specific for abetalipoproteinemia than the fatty acid abnormalities. However, the absence of these abnormalities in obligate heterozygous subjects makes their relationship to the primary defect of abetalipoproteinemia difficult to assess.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6027078      PMCID: PMC297114          DOI: 10.1172/JCI105608

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Some chemical characteristics of the lipids of human and bovine erythrocytes and plasma.

Authors:  D J HANAHAN; R M WATTS; D PAPAJOHN
Journal:  J Lipid Res       Date:  1960-10       Impact factor: 5.922

2.  The isolation and quantitation of the principle phospholipid components of human serum using chromatography on silicic acid.

Authors:  G B PHILLIPS
Journal:  Biochim Biophys Acta       Date:  1958-09

3.  Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins.

Authors:  D GITLIN; D G CORNWELL; D NAKASATO; J L ONCLEY; W L HUGHES; C A JANEWAY
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

4.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  The lipoproteins and lipid transport in abetalipoproteinemia.

Authors:  R I Levy; D S Fredrickson; L Laster
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

7.  The role of vitamin E deficiency in the abnormal autohemolysis of acanthocytosis.

Authors:  H J Kayden; R Silber; C E Kossmann
Journal:  Trans Assoc Am Physicians       Date:  1965

8.  Characterization and quantification of red cell lipids in normal man.

Authors:  P Ways; D J Hanahan
Journal:  J Lipid Res       Date:  1964-07       Impact factor: 5.922

9.  Peroxidative hemolysis of red blood cells from patients with abetalipoproteinemia (acanthocytosis).

Authors:  J T Dodge; G Cohen; H J Kayden; G B Phillips
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

10.  Studies on the absorptive defect for triglyceride in abetalipoproteinemia.

Authors:  P O Ways; C M Parmentier; H J Kayden; J W Jones; D R Saunders; C E Rubin
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

View more
  9 in total

1.  Chemical and kinetic study of the lipoproteins in abetalipoproteinaemic plasma.

Authors:  J Shepherd; M Caslake; E Farish; A Fleck
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

Review 2.  Disorders of the serum lipoproteins. I. Lipoprotein deficiency states.

Authors:  J K Lloyd
Journal:  Arch Dis Child       Date:  1968-08       Impact factor: 3.791

3.  A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques.

Authors:  D S Fredrickson; R I Levy; F T Lindgren
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

4.  Long-term management of abetalipoproteinaemia. Possible role for vitamin E.

Authors:  D P Muller; J K Lloyd; A C Bird
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

5.  Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.

Authors:  Peng Yang; Papasani V Subbaiah
Journal:  Biochim Biophys Acta       Date:  2015-07-18

6.  A study of the abnormal lipoproteins in abetalipoproteinemia.

Authors:  A M Scanu; L P Aggerbeck; A W Kruski; C T Lim; H J Kayden
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

7.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro.

Authors:  J A Glomset; K R Norum; W King
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

8.  Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.

Authors:  M J Malloy; J P Kane; D A Hardman; R L Hamilton; K B Dalal
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

Review 9.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.